刘颖;吴丽娥;郭霞;张佳;宋瑞琦;武俊平;贾璐;张晓芳;雍雯;

• 1:包头医学院第一附属医院

摘要(Abstract)：

目的探讨降压治疗对急性缺血性脑卒中预后的影响,比较早期降压与晚期降压的差异。方法纳入2018-10—2020-08包头医学院第一附属医院神经内科急性脑梗死合并血压升高的患者54例,随机分为早期降压组和晚期降压组,记录2组患者14 d、30 d NIHSS评分和30 d、90 d mRS评分,比较2组预后。结果早期和晚期降压组患者在发病后14d、30 d NIHSS评分比较差异均无统计学意义(P>0.05)。早期和晚期降压组患者在发病后30 d、90 d mRS评分比较差异均无统计学意义(P>0.05)。结论缺血性脑卒中急性期降压可能不获益,降压时间的早晚可能对预后无影响。

关键词(KeyWords)： 缺血性脑卒中;急性期;高血压;降压;预后

Abstract:

Keywords:

基金项目(Foundation): 科技部“十三五”国家重点研发计划项目(编号：2016YFC1307300)

作者(Author): 刘颖;吴丽娥;郭霞;张佳;宋瑞琦;武俊平;贾璐;张晓芳;雍雯;

Email:

DOI:

参考文献(References)：

• [1]ZHOU M,WANG H,ZHU J,et al.Cause-specific mortality for 240 causes in China during 1990-2013:a systematic subnational analysis for the Global Burden of Disease Study 2013[J].Lancet,2016,387(10015):251-272.DOI:10.1016/S0140-6736(15)00551-6.
• [2]GBD 2013 Mortality and Causes of Death Collaborators.Globai,regional,and national age-sex specific all-cause and cause-specific mortality for 240 causus of death,1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet,2015,385(9963):117-171.DOI:10.1016/S0140-6736(14)61682-2.
• [3]FEIGIN V L,KRISHNAMURTHI R V,PARMAR P,et al.GBD 2013 Writing Group;GBD 2013 Stroke Panel Experts Group.Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013:The GBD 2013Study[J].Neuroepidemiology,2015,45(3):161-176.DOI:10.1159/000441085.
• [4]WANG W,JIANG B,SUN H,et al.Prevalence,Incidence,and Mortality of Stroke in China:Results from a Nationwide Population-Based Survey of 480 687 Adults[J].Circulation,2017,135(8):759-771.DOI:10.1161/CIRCU-LATIONAHA.116.025250.
• [5]GIOVANE C,KWAG KH,SQUIZZATO A,at al.Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack:a systematic review and network meta-analysis[J].BMC Med,2019,17(1):67.DOI:10.1186/s12916-019-1298-5.
• [6]GBD 2016 Stroke Collaborators.Global,regional,and national burden of stroke,1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet Neurol,2019,18(5):439-458.DOI:10.1016/S1474-4422(19)30034-1.
• [7]ALBRIGHT K C,HUANG L,BLACKBURN J,at al.Racial differences in recurrent ischemic stroke risk and recurrent stroke case fatality[J].Neurology,2018,91(19):e1741-e1750.DOI:10.1212/WNL.0000000000006467.
• [8]SYLAJA P N,PANDIAN J D,KAUL S,at al.Ischemic Stroke Profile,Risk Factors,and Outcomes in India:The Indo-US Collaborative Stroke Project[J].Stroke,2018,49(1):219-222.DOI:10.1161/STROKEAHA.117.018700.
• [9]TSIVGOULIS G,PATOUSI A,PIKILIDOU M,at al.Stroke Incidence and Outcomes in Northeastern Greece:The Evros Stroke Registry[J].Stroke,2018,49(2):288-295.DOI:10.1161/STROKEAHA.117.019524.
• [10]WAFA H A,WOLFE C D A,RUDD A,at al.Long-term trends in incidence and risk factors for ischaemic stroke subtypes:Prospective population study of the South London Stroke Register[J].PLoS Med,2018,15(10):e1002669.DOI:10.1371/journal.pmed.1002669.
• [11]ZONNEVELD T P,RICHARD E,VERGOUWEN M D,at al.Blood pressure-lowering treatment for preventing recurrent stroke,major vascular events,and dementia in patients with a history of stroke or transient ischaemic attack[J].Cochrane Database Syst Rev,2018,7(7):CD007858.DOI:10.1002/14651858.CD007858.pub2.
• [12]Report on stroke prevention and treatment in China Writing Group.Brief report on stroke prevention and treatment in China,2019[J].Chin J Cerebrovasc Dis,2020,17(5):272-281.DOI:10.3969/j.issn.1672-5921.2020.05.008.
• [13]邢娟,白方会,付国惠,等.大剂量阿托伐他汀钙对急性脑梗死患者的保护作用[J].中国实用神经疾病杂志,2020,23(12):1063-1066.DOI:10.12083/SYSJ.2020.12.243.
• [14]WANG D,LIU J,LIU M,et al.Patterns of Stroke Between University Hospitals and Nonuniversity Hospitals in Mainland China:Prospective Multicenter Hospitalbased Registry Stud[J].World Neurosurg,2017,98:258-265.DOI:10.1016/j.wneu.2016.11.006.
• [15]ZHOU M,WANG H,ZENG X,at al.Mortality,morbidity,and risk factors in China and its provinces,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2019,394(10204):1145-1158.DOI:10.1016/S0140-6736(19)30427-1.
• [16]ALSIBAI A,QURESHI A I.Management of Acute Hypertensive Response in Patients With Ischemic Stroke[J].Neurohospitalist,2016,6(3):122-129.DOI:10.1177/1941874416630029.
• [17]BULWA Z,GOMEZ C R,MORALES-VIDAL S,at al.Management of Blood Pressure After Acute Ischemic Stroke[J].Curr Neurol Neurosci Rep,2019,19(6):29.DOI:10.1007/s11910-019-0941-z.
• [18]BAGER J E,HJALMARSSON C,MANHEM K,et al.Acute blood pressure levels and long-term outcome in ischemic stroke[J].Brain Behav,2018,8(6):e00992.DOI:10.1002/brb3.992.
• [19]THAKKAR P,MCGREGOR A,BARBER P A,at al.Hypertensive Response to Ischemic Stroke in the Normotensive Wistar Rat[J].Stroke,2019,50(9):2522-2530.DOI:10.1161/STROKEAHA.119.026459.
• [20]OH M S,YU K H,HONG K S,at al.Modest blood pressure reduction with valsartan in acute ischemic stroke:a prospective,randomized,open-label,blinded-end-point trial[J].Int J Stroke,2015,10(5):745-751.DOI:10.1111/ijs.12446.
• [21]HE J,ZHANG Y H,XU T,et al.Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke:the CATIS randomized clinical trial[J].JAMA,2014,311(5):479-489.DOI:10.1001/jama.2013.282543.
• [22]ZHANG R,ZHONG C,ZHANG Y,et al.Immediate Antihypertensive Treatment for Patients With Acute Ischemic Stroke With or Without History of Hypertension:ASecondary Analysis of the CATIS Randomized Clinical Trial[J].JAMA Netw Open,2019,2(7):e198103.DOI:10.1001/jamanetworkopen.2019.8103.
• [23]ROTHWELL P M.Blood pressure in acute stroke:which question remain?[J].Lancet,2015,385(9968):582-585.DOI:10.1016/S0140-6736(14)61898-5.
• [24]XU T,ZHANG Y,BU X,et al.Blood pressure reduction in acute ischemic stroke according to time to treatment:a subgroup analysis of the China Antihypertensive Trial in Acute Ischemic Stroke trial[J].J Hypertens,2017,35(6):1244-1251.DOI:10.1097/HJH.0000000000001288.
• [25]ENOS Trial Investigators.Efficacy of nitric oxide,with or without continuing antihypertensive treatment,for management of high blood pressure in acute stroke(ENOS):a partial-factorial randomised controlled trial[J].Lancet,2015,385(9968):617-628.DOI:10.1016/S0140-6736(14)61121-1.
• [26]MESCHIA J F,BROTT T.Ischaemic stroke[J].Eur JNeurol,2018,25(1):35-40.DOI:10.1111/ene.13409.
• [27]WANG Y,XU J,ZHAO X,et al.Association of hypertension with stroke recurrence depends on ischemic stroke subtype[J].Stroke,2013,44(5):1231-1237.DOI:10.1161/STROKEAHA.111.000302.
• [28]KHANEVSKI A N,BJERKREIM A T,NOVOTNY V,at al.Recurrent ischemic stroke:Incidence,predictors,and impact on mortality[J].Acta Neurol Scand,2019,140(1):3-8.DOI:10.1111/ane.13093.
• [29]HOWARD V J,MADSEN T E,KLEINDORFER D O,at al.Sex and Race Differences in the Association of Incident Ischemic Stroke With Risk Factors[J].JAMA Neurol,2019,76(2):179-186.DOI:10.1001/jamaneurol.2018.3862.
• [30]APPIAH K O,MINHAS J S,ROBINSON T G.Managing high blood pressure during acute ischemic stroke and intracerebral hemorrhage[J].Curr Opin Neurol,2018,31(1):8-13.DOI:10.1097/WCO.0000000000000508.
• [31]DICKIE D A,ARIBISALA B,MAIR G,at al.Blood pressure variability and leukoaraiosis in acute ischemic stroke[J].Int J Stroke,2018,13(5):473-480.DOI:10.1177/1747493017729267.
• [32]H?GG-HOLMBERG S,DAHLSTR?M E H,FORSB-LOM C M,at al.The role of blood pressure in risk of ischemic and hemorrhagic stroke in type 1 diabetes[J].Cardiovasc Diabetol,2019,18(1):88.DOI:10.1186/s12933-019-0891-4.
• [33]CIPOLLA M J,LIEBESKIND D S,CHAN S L.The importance of comorbidities in ischemic stroke:Impact of hypertension on the cerebral circulation[J].J Cereb Blood Flow Metab,2018,38(12):2129-2149.DOI:10.1177/0271678X18800589.
• [34]OFTEDAL?,GERDTS E,WAJE-ANDREASSEN U,at al.Prevalence and covariates of uncontrolled hypertension in ischemic stroke survivors:the Norwegian stroke in the young study[J].Blood Press,2018,27(3):173-180.DOI:10.1080/08037051.2018.1425827.
• [35]MA?ER B,KUBIS N.Hypertension and Its Impact on Stroke Recovery:From a Vascular to a Parenchymal Overview[J].Neural Plast,2019:6843895.DOI:10.1155/2019/6843895.
• [36]MORRISON H W,FILOSA J A.Stroke and the neurovascular unit:glial cells,sex differences,and hypertension[J].Am J Physiol Cell Physiol,2019,316(3):C325-C339.DOI:10.1152/ajpcell.00333.2018.
• [37]SHEKHAR S,VARGHESE K,LI M,at al.Conflicting Roles of 20-HETE in Hypertension and Stroke[J].Int J Mol Sci,2019,20(18):4500.DOI:10.3390/ijms20184500.
• [38]CANNISTRARO R J,BADI M,EIDELMAN B H,at al.CNS small vessel disease:A clinical review[J].Neurology,2019,92(24):1146-1156.DOI:10.1212/WNL.0000000000007654.
• [39]WEI W,LI S,SAN F,at al.Retrospective analysis of prognosis and risk factors of patients with stroke by TOAST[J].Medicine(Baltimore),2018,97(15):e0412.DOI:10.1097/MD.0000000000010412.
• [40]吴连爽,唐茜,王本玄,等.缺血性脑卒中静脉溶栓出血转化风险预测的研究进展[J].中国实用神经疾病杂志,2020,23(19):1744-1748.DOI:10.12083/SYSJ.2020.16.009.
• [41]BATH P M,APPLETON J P,KRISHNAN K,et al.Blood Pressure in Acute Stroke:To Treat or Not to Treat:That Is Still the Question[J].Stroke,2018,49(7):1784-1790.DOI:10.1161/STROKEAHA.118.021254.
• [42]POWERS W J,RABINSTEIN A A,ACHERSON T,et al.2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J].Stroke,2018,49(3):e46-e110.DOI:10.1161/STR.0000000000000158.